How long does the Ceris patent for Gvoke last?
I can’t answer that from the information provided here. The duration of Ceris’ patent protection for Gvoke depends on which specific patent(s) and jurisdiction you mean (and the “patent term” may be different from regulatory exclusivity).
Which patent are you asking about: the drug product or the method?
“Gvoke” (formerly dasiglucagon) may have multiple patent families covering different things (for example, formulation, dosing, or manufacturing). Each patent has its own expiry date, and companies often rely on more than one patent to maintain protection.
Where to check the exact expiry date
To get the exact “how long” answer, you’ll want one of these:
- The specific patent number(s) in the relevant country/region (e.g., US Orange Book for the US).
- The “expires” date shown in the patent listing tied to Gvoke.
- Any later expiry due to patent term adjustment/extension (common in the US) or other local rules.
If you share one detail, I can narrow it to the correct date
If you tell me either (a) the patent number, or (b) the country (US, EU, UK, etc.), I can explain how to interpret its listed expiry and what that means for when generic/biosimilar-style competition could begin.
Sources: None provided in the prompt.